Novartis' Bird Flu Vaccine Gets Positive EU Opinion After Two-Year Setback
This article was originally published in The Pink Sheet Daily
Executive Summary
Aflunov receives positive opinion after it replaced suspect data with results from new trials. The firm's new formulation of tobramycin for cystic fibrosis also gets thumbs up.